intermittent fasting and glp 1 + GLP-1 Injections: Smart or Dangerous? | Blog FASTING and Ozempic for Max

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Tailored for bariatric and GLP-1 patients: Designed to support hormone balance and estrogen metabolism in easy-to-swallow caplets, formulated to avoid dose-dumping and support gentle absorption* Bariatric must haves: Contains a unique blend of DIM, NAC and chasteberry extract, 3 powerful ingredients carefully selected for their ability to promote hormonal balance for women and support the unique needs of bariatric patients* Hormonal balance for women: DIM supports the metabolism of estrogen, while chasteberry may help ease the most common symptoms associated with the menstrual cycle and NAC provides antioxidant support to protect cells from oxidative stress* Formulated with you in mind: Our small, smooth-coated caplets are titanium-dioxide free, talc free, no artificial colors, dairy-free, and gluten-free and is designed to be gently absorbed without the stomach discomfort you may experience from other pills Committed to quality and care: Barimelts bariatric vitamins and supplements are produced in our NSF-certified GMP facility, and undergo third-party testing for potency and purity

Get real with side effect insights, practical tips, and community stories every listener can relate to

Pancreatic receptors enhance insulin release and improving blood glucose regulation after meals

Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss by Bartelt et al.

Grading of Recommendations Assessment, Development and Evaluation (GRADE) showed moderate certainty for MACE, all-cause death and hospitalization for HF